CELLDEX THERAPEUTICS INC (CLDX) Stock Balance Sheet
NASDAQ:CLDX - Nasdaq - US15117B2025 - Common Stock
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 36.40M | 34.81M | 29.40M | 39.10M | 43.80M | |||
| Marketable Securities | 719.60M | 388.78M | 275.50M | 369.10M | 150.60M | |||
| Receivables | 852.00K | 2.63M | 300.00K | 200.00K | 1.80M | |||
| Other Current Assets | 21.99M | 5.47M | 12.40M | 2.40M | 1.60M | |||
| Total Current Assets | 778.84M | 431.69M | 317.70M | 410.80M | 197.80M | |||
| Non-Current Assets | ||||||||
| PPE Net | 7.40M | 6.64M | 7.70M | 6.50M | 7.30M | |||
| Goodwill | N/A | N/A | N/A | N/A | N/A | |||
| Intangibles | 27.19M | 27.19M | 27.20M | 27.20M | 30.70M | |||
| Other Non-Current Assets | 9.75M | 107.00K | 100.00K | 100.00K | 0.00 | |||
| Total Non-Current Assets | 44.34M | 33.93M | 35.00M | 33.90M | 38.00M | |||
| TOTAL ASSETS | 823.18M | 465.63M | 352.70M | 444.70M | 235.80M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 29.58M | 23.64M | 14.30M | 13.70M | 9.80M | |||
| Accounts Payable | 1.11M | 3.49M | 3.30M | 1.20M | 1.00M | |||
| Other Current Liabilities | 1.40M | 3.99M | 1.00M | 1.60M | 3.40M | |||
| Total Current Liabilities | 32.09M | 31.13M | 18.60M | 16.50M | 14.20M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Deferred Taxes/Income | N/A | N/A | N/A | N/A | 1.80M | |||
| Other Non-Current Liabilities | 5.18M | 5.33M | 7.90M | 8.70M | 12.30M | |||
| Total Non-Current Liabilities | 5.18M | 5.33M | 7.90M | 8.70M | 12.30M | |||
| TOTAL LIABILITIES | 37.27M | 36.46M | 26.50M | 25.20M | 26.50M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -1.51B | -1.40B | -1.26B | -1.14B | -1.07B | |||
| Additional Paid In Capital | 2.29B | 1.82B | 1.58B | 1.56B | 1.28B | |||
| Common Shares | 66.00K | 56.00K | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | 2.60M | 2.60M | 2.60M | 2.60M | 2.60M | |||
| Shares Outstanding | 66.34M | 55.88M | 47.20M | 46.70M | 39.60M | |||
| Tangible Book Value per Share | 11.44 | 7.19 | 6.33 | 8.40 | 4.51 | |||
| Total Shareholders' Equity | 785.90M | 429.17M | 326.20M | 419.50M | 209.40M | |||
| TOTAL LIABILITIES AND EQUITY | 823.18M | 465.63M | 352.70M | 444.70M | 235.80M | |||
| Statistics | ||||||||
| Current Ratio | 24.27 | 13.87 | 17.08 | 24.90 | 13.93 | |||
| Return On Assets (ROA) | -18.72% | -30.37% | -31.85% | -15.86% | -25.35% | |||
| Return On Equity (ROE) | -19.61% | -32.95% | -34.44% | -16.81% | -28.55% | |||
All data in USD , ROIC based on taxRate of 0.21